Biofrontera (BFRI) Interest Expenses (2020 - 2025)

Biofrontera's Interest Expenses history runs 6 years deep, the most recent figure standing at $727000.0 for Q4 2025.

• On a quarterly basis, Interest Expenses rose 12016.67% year-over-year to $727000.0 in Q4 2025; TTM through Dec 2025 was $953000.0, a 46.31% decrease from a year earlier, with the FY2025 full-year figure at $731000.0, down 65.29% from the prior year.
• Interest Expenses advanced to $727000.0 in Q4 2025 per BFRI's latest filing, from $100000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $1.4 million in Q1 2024 and bottomed at -$253000.0 in Q4 2021.
• The 5-year median for Interest Expenses is $100000.0 (2022), against an average of $276789.5.
• Across the five-year window, Interest Expenses tumbled 122.41% in 2021 and surged 70950.0% in 2024, its largest moves.
• Year by year, Interest Expenses stood at -$253000.0 in 2021, then soared by 100.4% to $1000.0 in 2022, then jumped by 4700.0% to $48000.0 in 2023, then slumped by 87.5% to $6000.0 in 2024, then jumped by 12016.67% to $727000.0 in 2025.
• Per Business Quant, the three latest BFRI Interest Expenses figures stand at $727000.0 (Q4 2025), $100000.0 (Q3 2025), and $710000.0 (Q2 2025).